Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.41 -0.05%   SPY: 165.31 -0.09%
Quote Spy NVO NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Novo Nordisk (NVO)

@ May-24
Click the portfolio to add NVO:
Close [X]
+ Add NVO to Portfolio
  
  Last Trade: $168.64 -0.28 (-0.17%)
  Volume: 191,504 78% of avg daily volume
       
  Avg Volume: 245,067
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 167.12 - 168.94
  Open: 168.52
  Previous Close: 168.92
  52-wk Range: 129.41 - 194.44
  Market Cap: 92.0B
  P/E: 0.0
  Div Yield: $2.26 (1.34%)
Indexes
Big Pharmaceutical S... (0.0%)
Diabetes Stocks (+0.2%)
Spy NVO

? Pro holders
? Member holders
? Items submitted
Additional NVO resources



Customize Links
To see which Pros and tickerspy members own NVO Sign up now
Latest NVO Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Amgen Chased By The Bubble
ABT  PFE  MRK  AMGN  NVO  CELG  TEVA  BIIB  GILD  SNY  AFFY  HSP  
Linked by Investopedia Stock Analysis - May 08, 11:00AM from (www.investopedia.com)
Amgen really needs the pipeline to come through to support this valuation.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Emisphere Announces Amendment to Oral GLP-1 Development License Agreement With Novo Nordisk
NVO  EMIS  
Linked by GlobeNewswire - April 29, 08:43AM from (globenewswire.com)
ROSELAND, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that it has  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Merck’s $4 Billion Diabetes Drug in Trouble?
BMY  LLY  MRK  NVO  AZN  
Linked by YCHARTS - April 18, 11:55AM from (ycharts.com)
For the past two months, there has been rising controversy over the extent to which certain diabetes drugs called GLP-1 inhibitors  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
$35 Billion Diabetes Drug Market Up For Grabs, Pharma’s Sharp Elbows on Display
BMY  LLY  NVO  AZN  SNY  
Linked by YCHARTS - March 27, 06:14PM from (ycharts.com)
Eager to boost its diabetes business, Novo Nordisk (NVO) has been quick to hire spokespeople to tout its products and franchises.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trouble Ahead for Merck’s $4.1 Billion Januvia?
BMY  LLY  MRK  NVO  AZN  
Linked by YCHARTS - March 15, 04:30PM from (ycharts.com)
Two weeks ago, a newly study indicated that a pair of widely used diabetes drugs – Merck’s (MRK) Januvia and Bristol-Myers  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
10 Big-Name Stocks Going Ex-Dividend Next Week
TIF  NVO  IGT  BBY  MTN  TUP  HBC  AAP  LVS  AGNC  
Linked by The Dividend Daily - March 14, 02:30PM from (www.dividend.com)
Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
These ETFs Have Moving Average Problems
BP  DE  NVO  TEVA  POT  TOT  AZN  AGU  PTR  CHU  CHL  SNY  SNP  GSK  BG  ECA  CHA  LFC  CF  EC  FXI  IRY  MOS  IXC  PBR  MOO  
Linked by Benzinga.com - February 27, 03:23PM from (www.benzinga.com)
Let's quickly clear up that headline. Not all of the ETFs that will be highlighted here have violated a key moving average  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
FDA Decision on Diabetes Drug Hurts Novo Nordisk, Helps Sanofi
NVO  SNY  
Linked by YCHARTS - February 11, 03:51PM from (ycharts.com)
In a huge setback to Novo Nordisk (NVO), the FDA has rejected its new Tresiba insulin and wants a cardiovascular outcomes  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Denmark ETF Decked by Novo Nordisk's Slide
NVO  ERIC  NOK  GXF  
Linked by Benzinga.com - February 11, 11:53AM from (www.benzinga.com)
Shares of the rarely discussed iShares MSCI Denmark Capped Investable Market Index Fund (BATS: EDEN) are off by 3.2 percent  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Novo Nordisk Shares Fall After Delay in Approval
NVO  
Linked by NYTimes - February 11, 10:35AM from (www.nytimes.com)
Regulators in the United States have asked for more data in their review of the Danish company’s two long-acting insulin  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 12



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource